Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moss, S F
Right arrow Articles by Holt, P R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moss, S F
Right arrow Articles by Holt, P R
Gut 1999;45:723-729 ( November )

Article

Decreased and aberrant nuclear lamin expression in gastrointestinal tract neoplasms S F Mossa, V Krivosheyeva, A de Souzaa, K China, H P Gaetzb, N Chaudharyd, H J Wormanc, P R Holta

a Department of Medicine, Division of Gastroenterology, St Luke's-Roosevelt Hospital Centre, New York, USA, b Department of Pathology, St Luke's-Roosevelt Hospital Centre, New York, USA, c Departments of Medicine, Anatomy, and Cell Biology, College of Physicians and Surgeons, Columbia University, New York, USA, d Howard Hughes Medical Institute, Laboratory of Cell Biology, The Rockefeller University, New York, USA

Correspondence to: Dr S F Moss, Division of Gastroenterology, Department of Medicine, St Luke's-Roosevelt Hospital Centre, S&R 12, 1111 Amsterdam Ave, New York, NY 10025, USA.

Accepted for publication 2 June 1999

BACKGROUND---Altered expression of lamins A/C and B1, constituent proteins of the nuclear lamina, may occur during differentiation and has also been reported in primary lung cancer.
AIMS---To examine the expression of these proteins in gastrointestinal neoplasms.
PATIENTS---Archival human paraffin wax blocks and frozen tissue from patients undergoing surgical resection or endoscopic biopsy.
METHODS---Immunohistochemistry and western blotting using polyclonal antisera against A type lamins and lamin B1.
RESULTS---The expression of lamin A/C was reduced and was frequently undetectable by immunohistochemistry in all primary colon carcinomas and adenomas, and in 7/8 primary gastric cancers. Lamin B1 expression was reduced in all colon cancers, 16/18 colonic adenomas, and 6/8 gastric cancers. Aberrant, cytoplasmic labelling with both antibodies occurred in some colonic cancers and around one third of colonic adenomas. Cytoplasmic lamin A/C expression was detected in 3/8 gastric cancers. Lamin expression was reduced in gastric dysplasia, but not intestinal metaplasia, atrophy, or chronic gastritis. Lamin expression was low in carcinomas of oesophagus, prostate, breast, and uterus, but not pancreas.
CONCLUSIONS---Reduced expression of nuclear lamins, sometimes together with aberrant, cytoplasmic immunoreactivity is common in gastrointestinal neoplasms. Altered lamin expression may be a biomarker of malignancy in the gastrointestinal tract.


Keywords: nuclear lamins; biomarkers; gastrointestinal neoplasms


© 1999 by Gut



This article has been cited by other articles:


Home page
J. Cell Sci.Home page
E. Guffanti, N. Kittur, Z. N. Brodt, A. J. Polotsky, S. M. Kuokkanen, D. S. Heller, S. L. Young, N. Santoro, and U. T. Meier
Nuclear pore complex proteins mark the implantation window in human endometrium
J. Cell Sci., June 15, 2008; 121(12): 2037 - 2045.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. Zhang, H. Saitoh, and M. J. Matunis
Enzymes of the SUMO Modification Pathway Localize to Filaments of the Nuclear Pore Complex
Mol. Cell. Biol., September 15, 2002; 22(18): 6498 - 6508.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1999 BMJ Publishing Group Ltd & British Society of Gastroenterology